Delivery & Monitoring Platform

Current challenges in drug delivery

  1. Difficulty delivering past the Blood Brain Barrier, Blood-CSF, and Blood Arachnoid barriers. [1]

  2. Difficulty delivering to localized areas in the CNS

EnClear will improve therapeutic delivery through our ability to:

  1. Enable Targeted delivery through optimized flow rate, pulse width, volume, and controlled CSF recirculation

  2. Deliver at multiple access points within the CNS (e.g., lumbar, ventricular)

EnClear's Advantage

  1. Localized delivery past the BBB to areas of the CNS most benefited by therapeutics

  2. Controlled, continuous, and personalized therapeutic distribution in the CNS

* The EnClear platform is in early development, statements are currently under investigation.

1.https://www.cell.com/trends/chemistry/fulltext/S2589-5974(19)30100-5

EnClear Therapies, Inc.
65 Parker Street #3A. Newburyport, MA 01950

Phone: 978-358-1557

©2018 by EnClear Therapies. Proudly created with Wix.com